SK bioscience expands manufacturing facility in Korea for pneumococcal vaccine production

SK bioscience, South Korea-based vaccine and biotech company, has broken ground on a major expansion of its vaccine manu...

March 7, 2024 | Thursday | News
New research to investigate next generation ‘trans-amplifying’ mRNA vaccines

Scientists in the US are set to test a new vaccine approach that could overcome some of the challenges associated with t...

March 7, 2024 | Thursday | News
China Life Science Conference and China Life Science Expo (CILSE) Set to Drive Innovation and Collaboration in Guangzhou

The China Association for Science and Technology (CAS) Consortium of Life Sciences Societies is proud to announce the ...

March 7, 2024 | Thursday | News
Japan's NEC forges clinical development of Neoantigen Cancer Vaccine

Japan's NEC Corporation, AI and digital tech firm along with Transgene, which develops virus-based immunotherapies for c...

March 5, 2024 | Tuesday | News
Korea's International Vaccine Institute opens country office in Kenya

South Korea-based International Vaccine Institute (IVI) will open a Country and Project Office in Kenya dedicated to the...

March 5, 2024 | Tuesday | News
Medidata and Sanofi Vaccine partners to enable remote patient monitoring with real-time data collection

Medidata, a subsidiary of Dassault Systèmes, a leading provider of clinical trial solutions for the life sciences...

February 29, 2024 | Thursday | News
International Vaccine Institute to open Africa Regional Office in Rwanda

South Korea-based International Vaccine Institute (IVI), and the Ministry of Health of Rwanda have announced that IVI wi...

February 28, 2024 | Wednesday | News
Japan's Takeda accelerates dengue vaccine access through manufacturing partnership with Biological E in India

Japanese pharmaceutical company Takeda has announced a strategic partnership with Biological E, a le...

February 27, 2024 | Tuesday | News
Korea's SK bioscience obtains WHO prequalification for typhoid conjugate vaccine

SK bioscience, a South Korea-based vaccine and biotech company, has obtained prequalification (PQ) certification from th...

February 27, 2024 | Tuesday | News
US-based VBI Vaccines sells manufacturing capabilities to China's Brii Biosciences for $33 M

US-based VBI Vaccines Inc., a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and t...

February 16, 2024 | Friday | News
Experts advocate HPV Vaccination Programmes for Gynaecologic Cancer prevention in MENA region

The 16th Obstetrics and Gynaecology Conference took place on 30 January under the theme ‘From evidence to practice...

January 30, 2024 | Tuesday | Opinion
GSK Australia announces regulatory approval of respiratory syncytial virus vaccine AREXVY

GSK Australia has received Therapeutic Goods Administration (TGA) approval of AREXVY (respiratory syncytial virus v...

January 19, 2024 | Friday | News
Zuellig Pharma & Substipharm Biologics expand access to Japanese Encephalitis vaccine across Asia

Singapore-based Zuellig Pharma has announced its commercialisation partnership with French pharmaceutical company Substi...

January 16, 2024 | Tuesday | News
Singapore's Duke-NUS scientists discover potential nasal COVID-19 vaccine candidate

A team of scientists, led by Singapore’s Duke-NUS Medical School, has discovered a potential intranasal vaccine ca...

January 10, 2024 | Wednesday | News
CEPI partners with Korean biotech startup Lemonex to advance mRNA vaccine delivery

Norway-based Coalition for Epidemic Preparedness Innovations(CEPI) has partnered with Lemonex Inc. (Lemonex), a bi...

January 5, 2024 | Friday | News
Korea gives license to Euvichol-S, simplified formulation of oral cholera vaccine

The International Vaccine Institute (IVI) and EuBiologics Co have announced the licensure for export by the Korean Minis...

January 2, 2024 | Tuesday | News
CEPI and PATH strengthen partnership to accelerate development of vaccines

Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and US-based nonprofit global health organisation&nb...

December 19, 2023 | Tuesday | News
Novavax's updated COVID-19 vaccine receives emergency use authorisation in Taiwan

American firm Novavax, Inc., a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, h...

December 18, 2023 | Monday | News